Medical Decision Making in Multiple System Atrophy
A legfontosabb adatok
- Ki végzi
- Medical University Innsbruck
- Hol
- Innsbruck (Ausztria)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 92 fő, tervezett
- Kezdés
- 2023. okt. 1.
- Várható befejezés
- 2027. szept.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Telemedicine visits
- Multidisciplinary, personalized symptomatic treatment
- A regiszteradat frissítve
- 2025. február 5.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people with Multiple System Atrophy (MSA), a rare disease of the nervous system. Their unpaid caregivers can also join.
- Életkor
- People with MSA: 30 years or older. Caregivers: 18 years or older.
- Nem
- All sexes can join.
- A betegség stádiuma
- Clinically probable or clinically established MSA under the current MDS MSA criteria. Expected to live at least 24 months. People who cannot walk or stand without help must live in Tyrol or another Austrian region with mobile palliative care.
A részvétel fő kizáró okai
- Taking part in another treatment study that would interfere with this study's care plan, telemedicine or mobile palliative care
- Charlson comorbidity index above 4 (a score of other health problems)
- Other major health problems that could confuse the study results
- Not fluent in German
- Not able to give consent yourself (a legal representative cannot consent for you)
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- For individuals with MSA:
- Age ≥30 years at the time of consent
- Diagnosed with clinically probable or clinically established MSA according to the current MDS MSA criteria (1)
- Life-expectancy of at least 24 months as assessed by the investigator at the time of consent
- Understands and agrees to comply with the study procedures and provides written informed consent (Note: a legal representative may NOT provide consent on behalf of the subject)
- Signed and dated informed consent document
- Fluency in German
- If not able to walk or stand without assistance/support at the time of consent, the participant lives in Tyrol or in another Austrian Region with available mobile palliative care; For informal caregivers:
- Informal caregiver (i.e. person not receiving payment for his/her caregiving) of an individual with MSA recruited in the present study
- Life-expectancy of at least 24 months as assessed by the investigator at the time of consent
- Age≥ 18 years at the time of consent
- Understands and agrees to provide information as outlined in the study protocol and to engage in semi-structured online interviews
- Provides signed and dated written informed consent
- Full legal capacity
- Fluency in German
Ki nem vehet részt
- Other major underlying medical conditions that may confound interpretation of study results as assessed by the investigator
- For individuals with MSA
- Participation in an interventional clinical study at screening and throughout the study that would interfere with the MeDeMSA Care personalized treatment plan or would not permit telemedicine and mobile palliative care strategies
- Charlson comorbidity index >4 at the time of consent
Ez a vizsgálat jelenleg itt érhető el: Ausztria.
- Innsbruck Medical UniversityInnsbruck, AusztriaContact: Alessandra Fanciulli, MD PhDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical study is to evaluate the effects of a personalized symptomatic treatment plan integrated with monthly telemedicine and mobile palliative care interventions on a population of individuals diagnosed with Multiple System Atrophy (MSA) and their informal caregivers. The aim is to improve the quality of life of MSA patients and their caregivers, as well as provide them with better support during the disease progression.
A teljes eredeti leírásKevesebb
After a baseline visit, all 46 patients will receive a personalized therapeutic plan (including medical treatment, physiotherapy, logotherapy and occupational therapy excercises and psychological support) and contact with social workers and a palliative care team. They willl then be re-evaluated at 6-,12-, 18- month visits. Semi-structured online interviews at baseline and 12 month visit will collect patients' individual healthcare preferences, which will be taken into account in the preparation of the individual therapeutic plan. Twenty-three patients will be randomized to receive monthly telemedicine visits. Assessment of patients´satisfaction with the therapeutic plan, with the palliative interventions (when they occurred) and the telemedicine visits will be carried over the 18 month period.
Forty-six informal caregivers will be invited to participate with semi-structured online interviews and assessment of their QoL and caregivers' burden.
A vizsgálat 2 csoportja
- Group 1Már használt kezelés, összehasonlításként
Personalized best medical care.
Kezelés: Multidisciplinary, personalized symptomatic treatment
- Group 2A vizsgált kezelés
Personalized best medical care PLUS telemedicine
Kezelés: Telemedicine visits és Multidisciplinary, personalized symptomatic treatment
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Medical Decision Making in Multiple System Atrophy: Developing Personalized Best Medical Care with Integrated Telemedicine and Mobile Palliative Care for Individuals with Multiple System Atrophy
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2025. február 5.